可选产品分析
经您允许，我们会使用注重隐私的有限分析来了解哪些研究流程有效。我们不会使用广告跟踪器或会话录制。您可以在偏好设置中更改此选择。请阅读 隐私政策.
Accelerated customer conversion on energy-efficient compressor replacement cycles driven by elevated industrial electricity prices, which accelerates long-cycle 2027 project backlog realization while Precision & Science Technologies expands EBITDA margins toward the mid-30s.
Consolidated organic revenue growth decelerating below 1.0% YoY.
Ingersoll Rand Inc. (NYSE: IR) trades at $77.78 as of October 5, 2026, representing a 26.6% premium to our Fair Value estimate of $61.46 (-21.0% implied return), which underpins our Sell recommendation as market pricing exceeds fundamental valuation despite strong free cash flow conversion of approximately 95%.35
Ingersoll Rand Inc. (IR) is subject to a Sell recommendation, as its market price of $77.78 as of October 5, 2026 trades at a 26.6% premium above our Fair Value of $61.46, yielding an implied return of -21.0%. The company trades at a forward P/E of 19.34x, well above cyclical machinery peers such as Cummins at 15.28x. This valuation leaves no against macro headwinds and rising funding costs across its $4,849.5 million debt burden, which carries a 6.24% pre-tax .
Operational performance exhibits clear regional divergence. While North America generated $3,189.9 million in FY2025 (41.7% of sales) with resilient short-to-medium cycle industrial activity, international markets face significant strain. In EMEA ($2,601.5 million or 34.0% of FY2025 revenue), Q2 2026 organic orders declined low double digits due to long-cycle project phasing in blowers and vacuums. Concurrently, China ($789.5 million in FY2025 revenue) experienced intense original equipment price competition, leading management to guide full-year ITS margins below FY2025 levels.57
The core business benefits from a Narrow economic moat supported by mission-critical flow equipment and sticky aftermarket parts and service revenues across Industrial Technologies & Services ($6,056.4 million in FY2025 sales). Ingersoll Rand maintains low capital expenditure intensity of 1.77% of revenue ($135.6 million in FY2025), enabling management to target approximately 95% free cash flow conversion and support programmatic bolt-on M&A that adds approximately 2.5% to annual top-line growth.567
Management updated FY2026 revenue guidance to 4.5%–6.5%, supported by consensus expectations of $8,115.1 million in FY2026 revenue and $3.92 in FY2027 diluted EPS. Furthermore, high industrial electricity costs continue to drive secular payback demand for energy-efficient compressor upgrades, building project backlog into 2027. Nevertheless, these operational virtues are fully discounted at current multiples; under a 9.08% WACC and terminal exit multiple of 18.5x, fair value of $61.46 offers an unfavorable risk profile, justifying a Sell rating.125
Ingersoll Rand's Industrial Technologies & Services segment generated $6,056.4M in FY2025 (79.2% of consolidated revenue), where mission-critical compressed air installations generate sticky, high-margin aftermarket service and parts revenue that insulates cash flow across business cycles.7
With compressed air accounting for significant manufacturing electricity consumption, rising power prices shorten customer payback periods on replacing older equipment with energy-efficient models, building 6- to 18-month project backlog into 2027.5
Low capital expenditures of $135.6M in FY2025 (1.77% of revenue) allow management to guide approximately 95% free cash flow conversion, supporting consistent programmatic M&A that adds ~2.5% to annual revenue growth.56
We assign Ingersoll Rand a Sell rating with a Fair Value of $61.46 per share, indicating -21.0% implied return from the analysis price of $77.78. At current trading levels, the market prices Ingersoll Rand at a 26.6% premium to intrinsic value and 19.34x forward earnings. While the company possesses high operational quality, a Narrow economic moat, and resilient US industrial exposure ($3,189.9M in FY2025 revenue), this premium leaves no room for execution error amidst European order contraction and China pricing headwinds.357
Ingersoll Rand Inc. (NYSE: IR) is a global provider of mission-critical flow creation, air compression, and industrial solutions. The company operates through two primary reporting segments: Industrial Technologies & Services (ITS) and Precision & Science Technologies (PST). In FY2025, ITS generated $6,056.4 million (79.2% of consolidated revenue of $7,650.9 million), providing air compression systems, blowers, and vacuum pumps supported by a sticky installed base driving recurring aftermarket parts and services.
Precision & Science Technologies generated $1,594.5 million in FY2025 revenue (20.8% of sales), specializing in highly engineered positive displacement pumps, liquid and gas flow management, and specialized medical and lab equipment. By geography, the United States is the primary market, generating $3,189.9 million in FY2025 (41.7% of total revenue), followed by EMEA at $2,601.5 million (34.0%), Asia Pacific at $1,247.4 million (16.3%, with China accounting for $789.5 million), and Other Americas at $612.1 million (8.0%).
A macro stress scenario where European order deferrals spill over into North America, domestic Chinese original equipment pricing pressure persists, and corporate costs exceed the guided $170M ceiling would compress consolidated operating margins toward 13.5% (down from 14.96% in FY2025). Under these conditions, free cash flow conversion would fall below the guided 95% target, while a 100 bps expansion in WACC from 9.08% toward 10.1% alongside terminal P/E de-rating to 15.0x would compress intrinsic equity value toward the low-end fair value estimate of $27.12.
In the Bear scenario, industrial capital project deferrals in Europe deepen and spill into North America, while persistent price competition in China original equipment erodes gross profitability. High operating leverage and corporate overhead stickiness compress consolidated operating margins, leading free cash flow conversion to fall below guided levels and depressing cash generation.
EMEA generated $2,601.5M (34.0% of FY2025 revenue), where organic orders fell low double digits in Q2 2026 due to project delays. Management guidance relies on 1% to 3% full-year organic growth. If EMEA order deferrals spread to North America ($3,189.9M in FY2025 revenue), organic growth falling below 1.0% collapses top-line compounding.57
可能削弱我们投资逻辑的五项变化。
Signals that European blower and vacuum project delays are deepening into structural capex retrenchment rather than temporary phasing, impairing 34.0% of consolidated sales ($2,601.5M in FY2025).
当前：Down low double digits in Q2 2026
触发警报：Negative organic order growth for two consecutive quarters
Ingersoll Rand derives its narrow economic moat from high customer switching costs and an expansive global installed base across its core Industrial Technologies & Services (ITS) segment, which generated $6,056.4M or 79.2% of consolidated FY2025 revenue. Flow-control machinery, air compressors, and vacuum systems are mission-critical components embedded into customer manufacturing and chemical processing lines. Because the initial equipment purchase cost represents only a small fraction of the total lifetime electricity consumption and potential cost of facility downtime, industrial operators show strong reluctance to substitute unproven alternatives, locking in profitable parts, consumables, and maintenance service contracts throughout 10- to 20-year equipment lifecycles.
Global scale, specialized distribution networks, and the Ingersoll Rand Execution Excellence (IRX) operating system reinforce entry barriers by streamlining operational execution and localized product delivery. Core compressor demand in the United States ($3,189.9M in FY2025 revenue) remains resilient, insulated by deep commercial distribution partnerships and rapid field-service response capabilities. Furthermore, rising power prices shorten payback periods for replacing older, less efficient compressors, accelerating customer upgrade momentum.
However, the moat is bounded at Narrow rather than Wide due to the presence of substantial heavy capital equipment exposure where original equipment sales face cyclical tender competition. Particularly in China ($789.5M in FY2025 revenue), pricing pressure among original equipment manufacturers created measurable segment margin dilution in Q2 2026. Consequently, consolidated operating margin of 14.96% trails premium instrumentation peers such as Ametek at 26.18% and Parker-Hannifin at 23.46%.
Ingersoll Rand generates substantial economic profit through high aftermarket recurring revenues and asset-light operations (capex at 1.77% of FY2025 revenue of $7,650.9M). While unadjusted reported return on invested capital of 7.47% to 7.75% is constrained by accumulated goodwill from past business combinations, cash returns on tangible invested capital comfortably exceed the computed WACC of 9.08%, supported by guided ~95% free cash flow conversion.256
Each lens answers a different valuation question. Only included lenses set Fair value; floors and diagnostics provide context.
The highlighted cell is Fair value when every assumption sits at its base level ($61.46). Each row and column shows what Fair value becomes when one assumption moves.
Free cash flow to the firm stays positive in the first projected year at $849.1M after modeled reinvestment of $115.8M, with terminal value at 74.4% of enterprise value. A sudden drop in free cash flow is not projected unless capital spending relative to revenue, reinvestment, or gross margin resets materially.
The Base scenario models steady industrial compounding supported by ITS installed base aftermarket recurring revenues and disciplined execution. Operating margins expand gradually as corporate costs normalize to ~$170M and back-half direct material productivity materializes. International project deferrals in Europe and OE margin drag in China are absorbed as 6- to 18-month project backlog converts into 2027 revenue.57
Even in a scenario where full-year results exceed the top end of guidance, the market valuation already prices in substantial earnings acceleration, leaving the fair value range below current trading levels.
Results tracking within guided corridors confirm baseline compounder performance but do not bridge the valuation gap to current market quotes.
An execution miss driven by worsening project deferrals in Europe or continued margin degradation in China would validate the bear thesis and accelerate valuation multiple compression.
Earnings quality is structurally sound, evidenced by guided free cash flow conversion of approximately 95% and modest stock-based compensation of $53.0M in FY2025 (0.69% of revenue), which remains below the industrial benchmark of 0.90%. However, the wide variance between GAAP diluted EPS of $1.45 ($581.4M net income) and adjusted EPS guidance of $3.45 to $3.57 reflects heavy non-cash acquisition amortization, requiring investors to anchor on cash generation rather than adjusted accounting metrics.56
Post-earnings estimate momentum remained flat across consensus revisions following the Q2 earnings event, with FY2026 EPS consensus holding at $3.50 before drifting to $3.55, and FY2027 EPS consensus holding at $3.85 before drifting to $3.92. Revenue revision cohorts similarly remained flat around the release before reflecting the updated 4.5% to 6.5% top-line guidance.15
ITS accounts for 79.2% of consolidated sales ($6,056.4M in FY2025); sustaining organic growth confirms installed base stability.7
Ingersoll Rand exhibits consistent cash generation across industrial cycles. Operating cash flow reached $860.3M in FY2022 following free cash flow of $551.4M in FY2021. Capital expenditure requirements remain low, with FY2025 capex of $135.6M representing 1.77% of revenue, and normalized maintenance capex estimated at $108.5M (80% of total capex). With guided FY2026 free cash flow conversion of approximately 95%, free cash flow to firm is projected to reach $849.1M in FY2026 and compound toward $1,060.3M by FY2030.356
Headline ROIC appears muted due to accumulated goodwill from historical acquisitions, but underlying cash return on tangible capital remains robust. As operating margin expands from 14.96% in FY2025 toward 16.0% in FY2027 and 17.0% in FY2030, economic value creation will steadily expand.
Unadjusted reported ROIC of 7.47% to 7.75% sits below the computed WACC of 9.08% due to $8.48B in merger goodwill. However, cash return on tangible capital exceeds cost of capital, supported by low capex intensity (1.77% of revenue) and ~95% guided free cash flow conversion.
| 营业收入 | US$2,048,800,000 |
|---|---|
| 营业成本 | US$1,186,200,000 |
| 毛利 | US$862,600,000 |
| 营业费用 | US$482,300,000 |
| 营业利润 | US$380,300,000 |
| 营业外项目及税项 | -US$123,500,000 |
| 净利润 | US$256,800,000 |
| 总资产 | US$18,297,200,000 |
|---|---|
| 现金 | US$1,248,800,000 |
| 流动资产 | US$4,248,000,000 |
| 总负债 | US$8,143,200,000 |
| 流动负债 | US$2,066,300,000 |
| 股东权益 | US$10,154,000,000 |
| 净利润 | US$581,400,000 |
|---|---|
| 经营现金流入 | US$1,355,700,000 |
| 折旧与摊销 | US$505,800,000 |
| 股份支付 | US$53,000,000 |
| 其他经营调整项 | US$215,500,000 |
| 经营现金流 | US$1,355,700,000 |
| 可用现金 | US$2,963,200,000 |
| 期初现金 | US$1,541,200,000 |
| 汇率影响 | US$66,300,000 |
| 投资现金流出 | US$660,600,000 |
| 资本支出 | US$135,600,000 |
| 其他投资活动 | US$525,000,000 |
| 融资现金流出 | US$1,053,800,000 |
| 股份回购 | US$1,018,000,000 |
| 已付股息 | US$31,800,000 |
| 其他融资活动 | US$4,000,000 |
| 期末现金 | US$1,248,800,000 |
| 投资现金流 | -US$660,600,000 |
| 融资现金流 | -US$1,053,800,000 |
来源: SEC EDGAR · 申报日期 2026-02-17 · SEC EDGAR
| 按经营分部划分的收入 | 营业收入 | 占比 | 同比 |
|---|---|---|---|
| Industrial Technologies And Services | US$60.6亿 | 79.2% | 4.1% |
| Precision And Science Technologies | US$15.9亿 | 20.8% | 12.5% |
2026-10-05分析所采用的时点财务数据。
| 期间 | 营业收入 | EBITDA | 净利润 | 经营现金流 | 自由现金流 | 资本支出 | 折旧与摊销 | 股份支付 | 股份回购 | 已付股息 | 净债务发行 | 投资现金流 | 融资现金流 | 期初现金 | 期末现金 | 现金与投资 | 总债务 | 营业利润率 | ROIC | WACC | ROIC−WACC利差 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | US$19.4亿 | US$2.8亿 | -US$3660万 | US$1.7亿 | US$9120万 | US$7440万 | US$1.7亿 | US$0 | US$1410万 | US$99.2万 | — | -US$8210万 | -US$4300万 | — | US$2.6亿 | US$2.6亿 | US$37.3亿 | 5.3% | — | — | — |
| 2017-12-31 | US$23.8亿 | US$2亿 | US$1840万 | US$2亿 | US$1.4亿 | US$5680万 | US$1.7亿 | US$1.8亿 | US$360万 | US$20.1亿 | — | -US$6080万 | -US$1740万 | US$2.6亿 | US$3.9亿 | US$3.9亿 | US$29.8亿 | 4.6% | — | 7.9% | — |
| 2018-12-31 | US$26.9亿 | US$6.3亿 | US$2.7亿 | US$4.4亿 | US$3.9亿 | US$5220万 | US$1.8亿 | US$280万 | US$4070万 | US$5.2亿 | — | -US$2.4亿 | -US$3.7亿 | US$3.9亿 | US$2.2亿 | US$2.2亿 | US$37.5亿 | 16.5% | — | 5.1% | — |
| 2019-12-31 | US$20.2亿 | US$3.5亿 | US$1.6亿 | US$3.4亿 | US$3.1亿 | US$3790万 | US$1.5亿 | US$1870万 | US$1860万 | US$0 | — | -US$5430万 | -US$1150万 | US$2.2亿 | US$5.1亿 | US$5.1亿 | US$49.3亿 | 9.6% | — | 6.7% | — |
| 2020-12-31 | US$39.7亿 | US$4.8亿 | -US$3330万 | US$9.1亿 | US$8.7亿 | US$4200万 | US$4.1亿 | US$4750万 | US$210万 | US$0 | — | -US$3790万 | US$3.3亿 | US$5.1亿 | US$17.5亿 | US$17.5亿 | US$45.4亿 | 1.5% | — | 6.9% | — |
| 2021-12-31 | US$51.5亿 | US$10.2亿 | US$5.6亿 | US$6.2亿 | US$5.5亿 | US$6410万 | US$4.2亿 | US$8720万 | US$7.4亿 | US$820万 | — | US$9.1亿 | -US$11.6亿 | US$17.5亿 | US$21.1亿 | US$21.1亿 | US$5.9亿 | 11.0% | — | 6.5% | — |
| 2022-12-31 | US$59.2亿 | US$12.8亿 | US$6亿 | US$8.6亿 | US$7.7亿 | US$9460万 | US$4.3亿 | US$7890万 | US$2.6亿 | US$3240万 | -US$6.6亿 | -US$3.3亿 | -US$9.5亿 | US$21.1亿 | US$16.1亿 | US$16.5亿 | US$38.2亿 | 13.8% | — | 8.1% | — |
| 2023-12-31 | US$68.8亿 | US$16.5亿 | US$7.8亿 | US$13.8亿 | US$12.7亿 | US$1.1亿 | US$4.6亿 | US$5190万 | US$2.6亿 | US$3240万 | -US$2760万 | -US$10.6亿 | -US$3.4亿 | US$16.1亿 | US$16亿 | US$17.5亿 | US$27.7亿 | 16.9% | — | 8.4% | — |
| 2024-12-31 | US$72.4亿 | US$18.3亿 | US$8.4亿 | US$14亿 | US$12.5亿 | US$1.5亿 | US$4.8亿 | US$5880万 | US$2.6亿 | US$3230万 | US$20.5亿 | -US$31.1亿 | US$17.1亿 | US$16亿 | US$15.4亿 | US$15.4亿 | US$310万 | 18.0% | — | 9.5% | — |
| 2025-12-31 | US$76.5亿 | US$15.7亿 | US$5.8亿 | US$13.6亿 | US$12.2亿 | US$1.4亿 | US$5.1亿 | US$5300万 | US$10.2亿 | US$3180万 | US$0 | -US$6.6亿 | -US$10.5亿 | US$15.4亿 | US$12.5亿 | US$12.5亿 | US$48.5亿 | 15.0% | — | 8.3% | — |
Ingersoll Rand Inc. (IR) trades at 19.3x forward earnings against a peer median of 23.5x. Its EV/EBITDA of 16.5x compares with a peer median of 19.9x. The comparison uses 4 peers: Cummins Inc., Emerson Electric Co., AMETEK Inc. and Parker-Hannifin Corporation, as of 2026-10-03 to 2026-10-04.
Industry capex-to-revenue stands at 4.1% and industry capex-to-depreciation is 0.68, confirming disciplined reinvestment below depreciation rates across industrial machinery peers. Ingersoll Rand maintains even leaner operations, posting FY2025 capex of $135.6M or 1.77% of sales. Because specific sector capacity, supply lead-time, and customer-concentration evidence is unavailable in the data packet, this cycle view is demand-led and evidence-limited.6
An accelerating replacement upcycle where elevated industrial electricity costs shorten customer payback periods, converting 2027 project backlogs into double-digit organic growth and expanding operating margins toward 17.5%.
A cyclical downturn where long-cycle project deferrals in Europe ($2,601.5M FY2025 sales) spread into North America, compounding original equipment price competition in China and dragging organic growth below 1.0%.
Ingersoll Rand holds premier market share in flow creation and compressors via ITS ($6,056.4M in FY2025 sales) and specialized fluid handling via PST ($1,594.5M). Consolidated operating margin of 14.96% in FY2025 is in line with the industry benchmark of 16.1% and ahead of Cummins (11.90%), though trailing specialized peers like Ametek (26.18%) and Parker-Hannifin (23.46%).467
A 0.0% weight is recommended in alignment with the sell rating. At current trading levels, Ingersoll Rand trades at a 26.6% premium to the fair value midpoint of $61.46, leaving an unfavorable risk-reward skew.
Given the sell rating and elevated valuation (trading at $77.78 vs $61.46 fair value midpoint), risk management mandates total avoidance of new long exposure and prompt harvesting of existing gains. Portfolios holding legacy positions should utilize market liquidity to execute an orderly exit, eliminating exposure to European project deferrals, China original equipment margin pressure, and potential valuation multiple de-rating toward cyclical machinery averages.
Ingersoll Rand's Fair Value of $61.46 per share sits 21.0% below the current trading price of $77.78. Value investors should avoid the stock as it offers negative risk-adjusted returns and a 26.6% valuation premium under a 9.08% WACC.23
Although the company exhibits high-quality compounding metrics, including ~95% free cash flow conversion and disciplined capex at 1.77% of revenue, full-year organic growth of 1% to 3% does not justify paying 19.34x forward earnings.356
Negative organic order growth in EMEA blowers and vacuums and ongoing original equipment margin dilution in China present earnings vulnerability over the coming 6 to 12 months, limiting multiple expansion potential.5
We recommend a Sell rating on Ingersoll Rand Inc. (IR). At $77.78 per share as of October 5, 2026, the stock trades at a 26.6% premium to our intrinsic Fair Value of $61.46 (-21.0% implied return). While Ingersoll Rand is an operationally sound business with a Narrow moat and guided 95% free cash flow conversion, the market is pricing in aggressive terminal compounding while ignoring real European project delays and China original equipment margin dilution.35
At 19.34x forward earnings and a cost of capital of 9.08%, risk is heavily skewed to the downside. Investors should use current trading strength to trim or exit positions, reallocating capital toward industrial peers trading at discounts to intrinsic value.
Capture your own thesis, position size, and follow-up questions. Stays on this device, only you can see it.
The records this analysis drew on, as they stood when it was run.
Not every cited input appears here: internal calculations and intermediate model outputs have no external record, and some citations could not be matched to one.
China revenue of $789.5M created significant margin pressure in Q2 2026, leading management to project full-year ITS margins below FY2025. Compounded by sticky corporate costs ($49M in Q2 2026), intensified price competition drags consolidated operating margin from FY2025's 14.96% below 13.5%.567
The base valuation assumes a terminal P/E of 18.5x relative to current forward P/E of 19.34x. Cyclical machinery peer Cummins trades at 15.28x forward P/E. If Ingersoll Rand's organic growth stalls and the market re-evaluates IR as a cyclical machinery manufacturer rather than a premium automation peer, forward valuation multiple de-rating toward 15.0x drives substantial capital loss.34
Ingersoll Rand carries $4,849.5M in total debt with pre-tax cost of debt at 6.24% and current liabilities of $2,066.3M. Base computed WACC is 9.0757%. If debt refinancing spreads widen and equity beta expands above 1.095, WACC increasing by over 100 bps severely penalizes long-duration enterprise cash flows.236
Indicates that original equipment price competition in China and corporate overhead inflation cannot be offset by commercial pricing or direct material productivity.
当前：14.96% in FY2025
触发警报：Consolidated operating margin falling below 13.5%
Demonstrates persistent overhead cost stickiness beyond non-recurring incentive compensation true-ups, permanently reducing consolidated EBIT and free cash flow conversion.
当前：$49M in Q2 2026
触发警报：Full-year unallocated corporate costs exceeding $180M (vs $170M guidance)
Falsifies the core thesis that ITS installed base recurring aftermarket demand insulates top-line compounding from broader industrial economic slowdowns.
当前：Guided full-year organic growth of 1% to 3% for FY2026
触发警报：Consolidated organic revenue growth falling below 1.0% YoY
Refinancing debt obligations ($4,849.5M total debt) under elevated interest rates alongside equity beta expansion above 1.095 increases enterprise capital costs and contracts fair value.
当前：9.08%
触发警报：Weighted average cost of capital exceeding 10.1%
| medium |
| 6 to 12 months |
| Core compressor replacement demand in EMEA continues to grow low single digits organically, supported by high electricity rates that sustain ROI for energy efficiency upgrades.5 |
| Goodwill Dilution and Capital Misallocation From Bolt-On M&A | medium | 12 to 24 months | Management maintains strict valuation hurdles, focuses on niche proprietary technologies, and drives post-acquisition margin expansion via Ingersoll Rand Execution Excellence (IRX).5 |
Project EPS through the explicit advantage period, fade growth as competition catches up, and discount the full stream at cost of equity.
Apply a terminal P/E to the dated forward EPS path, then discount that future share value back to the analysis date.
Convert the revenue and margin path into after-tax free cash flow, discount the annual per-share amounts and terminal value at WACC, then adjust for signed net debt per current share.
Discounted forecast-period cash flows (US$9.30) plus discounted terminal value (US$27.07) minus signed per current share (US$9.28) equals the US$27.09 lens value shown above. Negative net debt is , so subtracting it raises value.
Add depreciation to net income, subtract maintenance capex, divide by diluted shares, and apply a normalized valuation multiple.
Multiply the peer median PEG by this stock's forecast growth to derive an implied forward P/E, then apply it to forward EPS.
Solve for the growth rate that makes the model value equal the report-date share price.
In the Bull scenario, rising industrial electricity costs dramatically accelerate compressor upgrade cycles across North America and Europe, driving double-digit organic order growth and swift backlog conversion through 2027. PST segment margins expand toward the mid-30s while direct material productivity and mix improvements push consolidated operating margins toward peer-leading levels, accelerating free cash flow compounding.5
EMEA generated 34.0% of FY2025 sales ($2,601.5M); order stabilization is necessary to prove project delays are timing-related.7
Corporate costs surged to $49M in Q2 2026; quarterly run-rates must normalize to achieve the guided $170M annual cap.5
High cash conversion underpins the mature compounder thesis and funds bolt-on acquisitions without equity dilution.
| $8.89B |
| $9.24B |
| $9.57B |
| Revenue growth | 6.1% | 4.8% | 4.5% | 4.0% | 3.5% |
| Operating margin | 15.5% | 16.0% | 16.5% | 16.8% | 17.0% |
| Operating income | $1.26B | $1.36B | $1.47B | $1.55B | $1.63B |
| Tax rate | 23.3% | 23.3% | 23.3% | 23.3% | 23.3% |
| NOPAT | $964.91M | $1.04B | $1.12B | $1.19B | $1.25B |
| Reinvestment | $115.79M | $135.69M | $157.47M | $178.66M | $187.11M |
| Reinvestment rate (of NOPAT) | 12.0% | 13.0% | 14.0% | 15.0% | 15.0% |
| Free cash flow to firm | $849.12M | $908.06M | $967.33M | $1.01B | $1.06B |
| Industrial Technologies and Services revenue | $6.42B | $6.73B | $7.03B | $7.32B | $7.57B |
| Precision and Science Technologies revenue | $1.69B | $1.77B | $1.85B | $1.93B | $1.99B |
| Terminal growth | 2.5% | 2.5% | 2.5% | 2.5% | 2.5% |
Capital allocation emphasizes programmatic bolt-on M&A and share repurchases over cash dividends. In FY2025, stock-based compensation of $53.0M was offset by repurchases. The dividend payout is low at $0.08 per share annually. Total debt stood at $4,849.5M at FY2025 ($4,906.7M as of 2026-10-05), resulting in a debt weight of 13.99% against market equity of $30,178.6M (86.01% equity weight). Management continues deploying free cash flow into acquisitions that contribute approximately 2.5% to top-line growth.
FY2025 capital expenditures were $135.6M, representing 1.77% of $7,650.9M in revenue, and management guides to ~95% free cash flow conversion for FY2026.
The business model converts the vast majority of operating profits directly into free cash flow ($849.1M projected for FY2026), providing ample internally generated liquidity for programmatic M&A without requiring equity issuance.
United States sales generated $3,189.9M in FY2025 (41.7% of total), whereas EMEA orders dropped low double digits in Q2 2026 and China ($789.5M FY2025 sales) created margin dilution.
Consolidated growth relies heavily on steady North American industrial demand to carry performance while international project deferrals resolve into 2027.
Unallocated corporate expenses increased to $49M in Q2 2026 compared to $34.6M in Q2 2025, with management guiding full-year corporate overhead to approximately $170M.
Achieving full-year margin targets requires corporate overhead to normalize to ~$35M-$40M per quarter in 2H 2026 alongside expected direct material productivity benefits.
| 利润率 |
|---|
| IR | Ingersoll Rand Inc. | $30.2B | 19.3x | 3.8x | 16.5x | 9.5% | — |
| CMI | Cummins Inc. | $72.9B | 15.3x | 2.1x | 15.6x | 21.1% | 11.9% |
| EMR | Emerson Electric Co. | $90.5B | 22.2x | 4.9x | 16.8x | 12.8% | 26.9% |
| AME | AMETEK Inc. | $57.7B | 26.3x | 7.3x | 23.8x | 14.6% | 26.2% |
| PH | Parker-Hannifin Corporation | $122.7B | 24.7x | 5.7x | 23.1x | 25.1% | 23.5% |
| negative |
| Intensifying domestic original equipment competition in China ($789.5M in FY2025 revenue) drives gross margin dilution across standard machinery lines. |
| Provides a margin of safety below fair value, adequately discounting macro capital expenditure contraction and discount rate risks. |
| Downgrade earnings forecast and cut terminal EBIT margin in DCF model. |
| EMEA Organic Order Trend | Negative organic order growth for two consecutive quarters | Trim 2027 revenue expectations and reflect structural European capex slowdown. |
| Unallocated Corporate Overhead | > $180M for full year 2026 (vs $170M guidance) | Incorporate permanent overhead friction into terminal free cash flow projections. |
| Free Cash Flow Conversion Rate | < 90% (vs ~95% guidance) | Reduce forward free cash flow estimates and evaluate working capital impairment. |
